Identification and characterization of functional antioxidant response elements in the promoter of the aldo-keto reductase AKR1B10 gene

被引:15
|
作者
Nishinaka, Toru [1 ]
Miura, Takeshi [2 ]
Shimizu, Kahori [1 ]
Terada, Tomoyuki [1 ]
机构
[1] Osaka Ohtani Univ, Fac Pharm, Lab Biochem, 3-11-1 Nishikiori Kita, Osaka 5848540, Japan
[2] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Pharmaceut Educ Support Ctr, 11-68 Koshien,9-Bancho, Nishinomiya, Hyogo 6638179, Japan
关键词
Aldo-keto reductase; Nrf2; AP-1; Antioxidant response element; Transcription; Lung; H23; A549; c-Jun; OLIGONUCLEOTIDE MICROARRAY; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CARCINOMA; OXIDATIVE STRESS; CANCER CELLS; MEMBER B10; TRANSCRIPTION; EXPRESSION; PATHWAY; GROWTH;
D O I
10.1016/j.cbi.2017.02.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AKR1B10 is a human-type aldo-keto reductase. The up-regulation of AKR1B10 has been associated with various cancers including non-small cell lung carcinoma, viral and bacterial infections, and skin diseases. However, the mechanisms underlying AKR1B10 gene regulation are not fully understood. We previously indicated the involvement of the transcription factor Nrf2 in AKR1B10 gene regulation. There are at least five potential Nrf2-responsive consensus sequences, so-called antioxidant response elements (AREs), and several ARE-like sequences in the 5'-flanking region up to -3282 bp of the AKR1B10 gene. In the present study, we attempted to identify functional AREs by luciferase reporter analyses using various mutants for each ARE. And we found that only those between -530 and -520 bp (ARE-A), which is the closest location to the translation start site, were functional among the five ARE consensus sites examined. Furthermore, ARE-A functioned co-operatively with the neighboring AP-1 site. Since the AP-1 site resembles ARE, the tandem arrangement of these two elements may be essential for augmented responsiveness to Nrf2 and plays an important role in AKR1B10 gene regulation by various Nrf2-mediating stimuli. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [1] Properties and tissue distribution of a novel aldo-keto reductase encoding in a rat gene (Akr1b10)
    Endo, Satoshi
    Matsunaga, Toshiyuki
    Kuragano, Tsukasa
    Ohno, Satoshi
    Kitade, Yukio
    Tajima, Kazuo
    El-Kabbani, Ossama
    Hara, Akira
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 503 (02) : 230 - 237
  • [2] Oxidation of PAH trans-Dihydrodiols by Human Aldo-Keto Reductase AKR1B10
    Quinn, Amy M.
    Harvey, Ronald G.
    Penning, Trevor M.
    CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (11) : 2207 - 2215
  • [3] Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
    Joshi, Amit
    Rajput, Sandeep
    Wang, Chun
    Ma, Jun
    Cao, Deliang
    BIOLOGICAL CHEMISTRY, 2010, 391 (12) : 1371 - 1378
  • [4] Structure and promoter characterization of aldo-keto reductase family 1 B10 gene
    Liu, Ziwen
    Zhong, Linlin
    Krishack, Paulette A.
    Robbins, Sarah
    Cao, Julia X.
    Zhao, Yupei
    Chung, Stephen
    Cao, Deliang
    GENE, 2009, 437 (1-2) : 39 - 44
  • [5] Regulation of aldo-keto reductase AKR1B10 gene expression: Involvement of transcription factor Nrf2
    Nishinaka, Toru
    Miura, Takeshi
    Okumura, Manami
    Nakao, Fumika
    Nakamura, Haruka
    Terada, Tomoyuki
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 191 (1-3) : 185 - 191
  • [6] Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
    Chung, Yeon Tae
    Matkowskyj, Kristina A.
    Li, Haonan
    Bai, Han
    Zhang, Wanying
    Tsao, Ming-Sound
    Liao, Jie
    Yang, Guang-Yu
    MODERN PATHOLOGY, 2012, 25 (05) : 758 - 766
  • [7] Aldo-keto reductase family 1B10 (AKR1B10): Novel biomarker and molecular target of hepatocellular carcinoma
    Bai, Han
    Zhang, Wanying
    Li, Haonan
    Matkowskyj, Kristina A.
    Yang, Allison L.
    Liao, Jie
    Yang, Guang-Yu
    CANCER RESEARCH, 2012, 72
  • [8] Identification of Aldo-Keto Reductase AKR1B10 as a Selective Target for Modification and Inhibition by Prostaglandin A1: Implications for Antitumoral Activity
    Diez-Dacal, Beatriz
    Gayarre, Javier
    Gharbi, Severine
    Timms, John F.
    Coderch, Claire
    Gago, Federico
    Perez-Sala, Dolores
    CANCER RESEARCH, 2011, 71 (12) : 4161 - 4171
  • [9] Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer
    Taskoparan, Betul
    Seza, Esin Gulce
    Demirkol, Secil
    Tuncer, Sinem
    Stefek, Milan
    Gure, Ali Osmay
    Banerjee, Sreeparna
    CELLULAR ONCOLOGY, 2017, 40 (06) : 563 - 578
  • [10] Proteomic identification of aldo-keto reductase AKR1B10 induction after treatment of colorectal cancer cells with the proteasome inhibitor bortezomib
    Loeffler-Ragg, Judith
    Mueller, Doris
    Gamerith, Gabriele
    Auer, Thomas
    Skvortsov, Sergej
    Sarg, Bettina
    Skvortsova, Ira
    Schmitz, Klaus J.
    Martin, Hans-Joerg
    Krugmann, Jens
    Alakus, Hakan
    Maser, Edmund
    Menzel, Juergen
    Hilbe, Wolfgang
    Lindner, Herbert
    Schmid, Kurt W.
    Zwierzina, Heinz
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (07) : 1995 - 2006